Status:
UNKNOWN
Study of Pulmonary Hypertension in Patients With Chronic Myeloproliferative Disorders at Sohag University Hospital
Lead Sponsor:
Sohag University
Conditions:
Chronic Myeloproliferative Disorders
Eligibility:
All Genders
18+ years
Brief Summary
Pulmonary hypertension (PH) is a complex condition that may be related to many clinical conditions. It is a serious disorder with a high morbidity and mortality rates. PH is classified into five group...
Eligibility Criteria
Inclusion
- Patients over 18 years old.
- Patients diagnosed with polycythemia vera, essential thrombocythemia, primary myelofibrosis and chronic myeloid leukemia according to the 2016 WHO classification and attended the outpatient Hematology Clinic at Sohag University Hospital.
Exclusion
- Patients less than 18 years old.
- Patients with pre-existing pulmonary hypertension from any other cause.
- Patients with left sided heart disease e.g. left sided heart failure, left sided valvular diseases, cardiomyopathies, left ventricular systolic or diastolic dysfunction.
- Patients with chronic lung disease e.g. COPD \& interstitial lung disease.
- Patients with chronic kidney disease.
- Patients with connective tissue diseases.
- Patients with congenital heart diseases.
Key Trial Info
Start Date :
May 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2023
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT04843475
Start Date
May 1 2021
End Date
January 1 2023
Last Update
April 15 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.